✨ Free AI Report
Aquestive Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Aquestive Therapeutics, Inc.
Company Research

Aquestive Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Aquestive Therapeutics, Inc. is a leading pharmaceutical company specializing in innovative drug delivery solutions. With a commitment to improving patients’ lives, Aquestive Therapeutics has...

Analyst-debate audio for Aquestive Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Aquestive Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company Overview of Aquestive Therapeutics, Inc.Product Portfolio of Aquestive Therapeutics, Inc.Leadership and Management Team of Aquestive Therapeutics, Inc.Financial Overview of Aquestive Therapeutics, Inc.Marketing Strategies of Aquestive Therapeutics, Inc.Market Overview and Competitors of Aquestive Therapeutics, Inc.
Get Interactive Report Freeor start reading below
Live on AskCyborg
4/10Mixed
Aquestive Therapeutics, Inc.

Aquestive's first-in-class Anaphylm program faces near-term regulatory hurdles but Q3 2026 resubmission and international expansion offer meaningful upside if clinical readouts...

▶︎ Listen to the 90-second analyst debate
Competitors covered:Pfizer Inc.
4/ 10Mixed

Cyborg Score thesis

Aquestive's first-in-class Anaphylm program faces near-term regulatory hurdles but Q3 2026 resubmission and international...

Read the full analyst-debate transcript →
Industry Pharmaceutical/Specialty Pharmaceuticals (Allergy/Emergency Medicine)
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest Aquestive Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Aquestive Therapeutics, Inc. is a leading pharmaceutical company specializing in innovative drug delivery solutions. With a commitment to improving patients’ lives, Aquestive Therapeutics has carved a niche in the healthcare industry by developing novel therapies that address unmet medical needs. This remarkable journey of innovation and dedication has made the company a formidable player in the pharmaceutical sector.

Company Overview of Aquestive Therapeutics, Inc.

Pro stress-test →

Founded in 2004 and headquartered in Warren, New Jersey, Aquestive Therapeutics, Inc. is at the forefront of pharmaceutical innovation. The company focuses on developing and commercializing treatments that leverage its cutting-edge PharmFilm® technology, which allows for efficient drug delivery through oral films. Aquestive’s mission is to provide patients with more accessible and effective treatment options, enhancing their quality of life.

Product Portfolio of Aquestive Therapeutics, Inc.

Pro stress-test →

Aquestive Therapeutics boasts a diverse product portfolio designed to address various therapeutic areas. Key products include:

  • Sympazan®: An oral film indicated for the treatment of seizures associated with Lennox-Gastaut syndrome.
  • Suboxone® (partnered): A film used for the treatment of opioid dependence.
  • Exservan™: An oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosis (ALS).

Leadership and Management Team of Aquestive Therapeutics, Inc.

Pro stress-test →

The leadership team of Aquestive Therapeutics, Inc. is composed of seasoned professionals with vast experience in the pharmaceutical industry. Key members include:

  • Keith Kendall: CEO and President, driving strategic growth and innovation.
  • Daniel Barber: Chief Operating Officer, overseeing operations and development.
  • John Maxwell: Chief Financial Officer, managing financial strategy and performance.

Financial Overview of Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. has demonstrated robust financial performance with steady revenue growth. The company’s strategic partnerships and product launches have contributed significantly to its financial stability. Key financial metrics include:

  • Annual Revenue: Approximately $45 million.
  • Market Capitalization: Around $150 million.
  • R&D Expenditure: Significant investment in research and development to drive innovation.

Marketing Strategies of Aquestive Therapeutics, Inc.

Aquestive Therapeutics employs a comprehensive marketing strategy to promote its products. This includes:

  • Targeted advertising campaigns.
  • Collaborations with healthcare providers.
  • Educational initiatives to raise awareness about their novel drug delivery systems.

Market Overview and Competitors of Aquestive Therapeutics, Inc.

The pharmaceutical market is highly competitive, with numerous players striving for dominance. Key competitors of Aquestive Therapeutics include:

  • Indivior PLC.
  • BioDelivery Sciences International, Inc.
  • IntelGenx Technologies Corp.

Despite the competition, Aquestive’s unique product offerings and innovative technologies provide a competitive edge.

Sales Strategies of Aquestive Therapeutics, Inc.

Aquestive Therapeutics utilizes multiple sales channels to reach its target audience. These include:

  • Direct sales to healthcare providers.
  • Partnerships with pharmaceutical distributors.
  • Online sales platforms.

Technologies Utilized by Aquestive Therapeutics, Inc.

Aquestive’s PharmFilm® technology is a standout innovation, enabling the development of oral film formulations that offer precise dosing and ease of administration. This technology sets the company apart in the drug delivery landscape.

HR Practices at Aquestive Therapeutics, Inc.

Aquestive Therapeutics places a strong emphasis on fostering a positive workplace culture. HR practices include:

  • Comprehensive training and development programs.
  • Employee wellness initiatives.
  • Inclusive hiring practices.

Corporate Responsibility of Aquestive Therapeutics, Inc.

The company is committed to corporate social responsibility, engaging in various initiatives such as:

  • Environmental sustainability programs.
  • Community outreach and support.
  • Ethical business practices.

Future Plans of Aquestive Therapeutics, Inc.

Aquestive Therapeutics is poised for continued growth with several strategic initiatives in the pipeline, including:

  • Expansion of the product portfolio.
  • Entering new therapeutic areas.
  • Strengthening global market presence.

Unlock the full potential of Aquestive Therapeutics, Inc. by subscribing to our detailed report.

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Aquestive Therapeutics, Inc..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Aquestive Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Aquestive Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Aquestive Therapeutics, Inc. operates in Pharmaceutical/Specialty Pharmaceuticals (Allergy/Emergency Medicine). See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical/Specialty Pharmaceuticals (Allergy/Emergency Medicine) research →
NEW · MCP server

Ask your AI assistant about Aquestive Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Aquestive Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Aquestive Therapeutics, Inc. do this quarter?”
“Is Aquestive Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Aquestive Therapeutics, Inc. do?+
Aquestive Therapeutics, Inc. is a leading pharmaceutical company specializing in innovative drug delivery solutions. With a commitment to improving patients’ lives, Aquestive Therapeutics has...
What is Aquestive Therapeutics, Inc.'s Cyborg Score?+
Aquestive Therapeutics, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Aquestive Therapeutics, Inc.'s main competitors?+
Named competitors include EpiPen (epinephrine autoinjector), Auvi-Q (epinephrine autoinjector). The full competitive landscape is in the AskCyborg report.
How can I get the full Aquestive Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Aquestive Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Aquestive Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed